Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 7/20 | 0.42 |
| ▸ | CA2 | P00918 | 7/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.42 |
| ▸ | CA9 | Q16790 | 6/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA7 | P43166 | 3/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL984211 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL11155064 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL65782 | 1.00 | — | — | |
| SCHEMBL545411 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL9146095 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL11350530 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL980873 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL984562 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL984213 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A | |
| SCHEMBL17744189 | 1.00 | TSHR (0.50) | TSHRTHRBMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894239-B2 | Dispersant, dispersion composition, and fibrous sheet | MEISEI CHEMICAL WORKS, LTD. (JP) | 2021-01-19 | — | — | US | disclosed |
| EP-3135369-B1 | USE OF DISPERSANT,DISPERSION COMPOSITION AND FIBROUS SHEET | MEISEI CHEMICAL WORKS LTD (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10731159-B2 | Cationic lipid | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| US-20200080086-A1 | CATIONIC LIPID | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-03-12 | — | — | US | disclosed |
| EP-3020701-B1 | NOVEL LIPID | DAIICHI SANKYO CO LTD (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-20180051285-A1 | CATIONIC LIPID | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-02-22 | — | — | US | disclosed |
| US-9803199-B2 | Cationic lipid | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20170080397-A1 | DISPERSANT, DISPERSION COMPOSITION, AND FIBROUS SHEET | MEISEI CHEMICAL WORKS, LTD. (JP) | 2017-03-23 | — | — | US | disclosed |
| EP-3135369-A1 | DISPERSANT, DISPERSION COMPOSITION, AND FIBROUS SHEET | MEISEI CHEMICAL WORKS, LTD. (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20160257951-A1 | NOVEL LIPID | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-09-08 | — | — | US | disclosed |
| EP-3020701-A1 | NOVEL LIPID | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-05-18 | — | — | EP | disclosed |
| US-5616581-A | BACTERICIDES | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| US-5504082-A | BACTERICIDE FOR HELICOBACTER, ANTIULCER AGENT, GASTRIC ACIDSUPPRESSOR | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-04-02 | — | — | US | disclosed |
| EP-0644191-A1 | PYRIDINE COMPOUND AND MEDICINAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160257951-A1 | NOVEL LIPID | NPC1L1, CETP, LIPC | TSHR 4094/4885THRB 4781/4885MEN1 2761/4885 |
| US-20180051285-A1 | CATIONIC LIPID | CETP, NPC1L1, LIPA | TSHR 3456/4885THRB 4651/4885MEN1 2072/4885 |
| US-20200080086-A1 | CATIONIC LIPID | CETP, NPC1L1, LIPA | TSHR 3456/4885THRB 4651/4885MEN1 2072/4885 |
| US-10731159-B2 | Cationic lipid | CETP, NPC1L1, LIPA | TSHR 3456/4885THRB 4651/4885MEN1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.